Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupuncture Combined With Moxibustion vs Loratadine for Perennial Allergic Rhinitis
NCT02339714Phase 2Completed
- Start
- Mar 2015
- Primary completion
- May 2016
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms). Primary endpoint: Total Nasal Symptom Score at 4 weeks. Started Mar 2015; status: completed.
Beyond the preview
Go deeper on NCT02339714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02339714.